BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 337 filers reported holding BIONTECH SE in Q3 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,553,838 | +3.3% | 419,310 | +2.7% | 0.05% | +8.0% |
| Q2 2023 | $44,080,232 | -1.9% | 408,415 | +13.2% | 0.05% | -3.8% |
| Q1 2023 | $44,926,758 | -15.1% | 360,655 | +2.4% | 0.05% | -17.5% |
| Q4 2022 | $52,921,947 | +42.3% | 352,262 | +27.8% | 0.06% | +31.2% |
| Q3 2022 | $37,188,000 | -21.2% | 275,710 | -12.9% | 0.05% | -17.2% |
| Q2 2022 | $47,197,000 | -43.5% | 316,544 | -35.4% | 0.06% | -31.8% |
| Q1 2022 | $83,566,000 | +7.2% | 489,951 | +62.0% | 0.08% | +11.8% |
| Q4 2021 | $77,954,000 | -22.7% | 302,382 | -18.2% | 0.08% | -30.3% |
| Q3 2021 | $100,900,000 | +345.5% | 369,609 | +265.3% | 0.11% | +336.0% |
| Q2 2021 | $22,650,000 | +45.0% | 101,169 | -29.3% | 0.02% | +31.6% |
| Q1 2021 | $15,621,000 | – | 143,058 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |